Monika Staniszewska | Biology | Best Researcher Award

Published on by Research Awards

Best Researcher Award

Warsaw University of Technology (WUT), Poland

Monika Staniszewska
Affiliation Warsaw University of Technology (WUT)
Country Poland
Scopus ID 23499927600
Documents 92
Citations 1,643
h-index 20
Subject Area Biology
Event International Research Awards
ORCID 0000-0002-6271-3482

Monika Staniszewska is a researcher affiliated with Warsaw University of Technology (WUT), Poland, whose research profile is associated with the subject area of Biology. Her scholarly record, as represented by the supplied Scopus profile information, comprises 92 documents, 1,643 citations and an h-index of 20. These bibliometric indicators provide quantitative information about her indexed research publications and their citation impact.  [1] [2]

Abstract

This academic profile presents the research background and bibliometric information associated with Monika Staniszewska, affiliated with Warsaw University of Technology (WUT), Poland. Her identified subject area is Biology. According to the supplied Scopus profile metrics, her scholarly output includes 92 indexed documents, which have received 1,643 citations, with an h-index of 20. These indicators provide an overview of her publication activity and citation visibility within the indexed scholarly literature. Her academic identity is further supported by her Scopus Author ID and ORCID record. [1] [2]

Keywords

Monika Staniszewska, Biology Research, Warsaw University of Technology, Academic Research, Scientific Publications, Research Impact, Bibliometric Indicators, International Research Awards. [1]

Introduction

Academic research contributes to the advancement of scientific knowledge through systematic investigation, publication and the dissemination of findings. Researchers working in Biology contribute to the development of scientific understanding through research activities addressing biological systems, processes and related areas of inquiry. [1] [2]

Research Profile

Monika Staniszewska’s research profile is identified through her institutional affiliation, subject classification and indexed scholarly output. The available information associates her with Warsaw University of Technology (WUT), Poland, and the subject area of Biology.[5]

Research Contributions

Research contributions are generally evaluated through the originality, methodological quality, reproducibility and relevance of scholarly investigations. In Biology, research may address a broad range of topics involving living organisms, biological mechanisms, cellular processes and interactions within biological systems.[4]

Publications

The supplied Scopus information records 92 documents associated with Monika Staniszewska’s author profile. These documents form the indexed publication output reported for the profile. The Scopus author record provides a bibliographic source for examining available publication entries, author associations and citation information. [1]

Research Impact

Research impact can be assessed through several complementary approaches, including citation analysis, publication visibility, research collaboration, practical application and contributions to scientific development. Bibliometric indicators provide one quantitative perspective on the influence and visibility of scholarly publications. [3]

Award Suitability

The International Research Awards provide a context for recognizing scholarly activity and research contributions across academic disciplines. Monika Staniszewska’s supplied academic profile includes an institutional affiliation with Warsaw University of Technology (WUT), a Biology subject classification and a documented bibliometric record consisting of 92 documents, 1,643 citations and an h-index of 20.[1]

Conclusion

Monika Staniszewska is an academic researcher affiliated with Warsaw University of Technology (WUT), Poland, and associated with the subject area of Biology. Her supplied Scopus profile metrics report 92 indexed documents, 1,643 citations and an h-index of 20. Her Scopus Author ID and ORCID provide identifiers through which her scholarly profile can be examined and distinguished.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Monika Staniszewska, Author ID 23499927600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=23499927600
  2. ORCID. (n.d.). Monika Staniszewska – ORCID researcher record. ORCID.
    https://orcid.org/0000-0002-6271-3482
  3. International Research Awards. (n.d.). Official award website.
    https://researchawards.net/
  4. Garofalo, M., Staniszewska, M., Salmaso, S., Caliceti, P., & Kuryk, L. (2025). Oncolytic adenovirus-based immunotherapy for malignant mesothelioma: Preclinical advances and future perspectives. Advancements of Microbiology.
    https://doi.org/10.2478/am-2025-0004
  5. Gadakh, S., Szczepińska, T., Potoczna, M., Okitsu-Sakurayama, S., Podlasz, P., Rogalska, M., Kaczorowska, E., Adamczyk-Woźniak, A., & Staniszewska, M. (2024). On the mode of anti-C. albicans activity of a bis(benzoxaborole) analogue of Tavaborole. Preprint.
    https://doi.org/10.1101/2024.07.29.605614

 

 

Lang Li | Biology | Research Excellence Award

Published on by Research Awards

Research Excellence Award

Lang Li · The Ohio State University, United States

Lang Li
Affiliation The Ohio State University
Country United States
Scopus ID 35272883700
Documents 348
Citations 13,802
h-index 61
Subject Area Biology
Recognition Research Excellence Award
Event International Research Awards
ORCID 0000-0002-0746-1809

The Research Excellence Award recognizes research contributions, scholarly productivity, and academic impact across scientific disciplines. This article presents the available bibliometric information associated with Lang Li, affiliated with The Ohio State University in the United States, and outlines the research profile in the context of biology and the International Research Awards. The publication and citation figures presented here are supplied profile data and should be interpreted with reference to the relevant bibliographic record. [1] [2]

Abstract

This article presents the academic profile of Lang Li, affiliated with The Ohio State University, United States, and associated with the subject area of biology. The supplied bibliometric record reports 348 documents, 13,802 citations, and an h-index of 61. These indicators provide a quantitative overview of publication output and citation activity. The profile is presented in connection with the Research Excellence Award under the International Research Awards. The information is intended to summarize research visibility and scholarly productivity while recognizing that bibliometric indicators alone cannot establish research quality, originality, or award selection outcomes. [1] [2]

Keywords

Research Excellence Award; Lang Li; The Ohio State University; biology research; scientific publications; bibliometrics; citation analysis; h-index; research impact; academic recognition; International Research Awards.[3]

Introduction

Research excellence is commonly assessed through a combination of scholarly output, methodological rigor, originality, reproducibility, and contributions to the advancement of knowledge. Publication and citation indicators can help describe the visibility of academic work, although their interpretation depends on disciplinary practices, publication history, and database coverage. [3]

Research Profile

Lang Li is identified in the supplied information as affiliated with The Ohio State University in the United States. The provided subject area is biology. The associated Scopus author identifier is 35272883700, and the supplied ORCID identifier is 0000-0002-0746-1809. These identifiers offer routes for examining author records and checking the relationship between publications and the researcher. [1] [2]

Research Contributions

The supplied profile indicates a substantial body of indexed scholarly output. However, the available input does not identify individual research projects, specific discoveries, research methods, or subject specializations within biology. Accordingly, this section does not assign particular scientific findings to Lang Li without supporting publication-level evidence.

Publications

The supplied Scopus profile information reports 348 documents. This figure represents the document count provided for the researcher and should be verified against the current database record before publication. The total may depend on indexing coverage, document types, author-profile consolidation, and the date on which the record is accessed. [4]

Research Impact

The supplied profile reports 13,802 citations and an h-index of 61. Citation counts describe how frequently indexed documents have been cited, while the h-index combines publication productivity and citation frequency into a single indicator. These measures can help characterize scholarly visibility but do not independently demonstrate research quality, practical significance, or societal benefit. [1] [3]

Award Suitability

The Research Excellence Award is presented here as the recognition associated with this profile. The reported publication count, citation count, and h-index provide quantitative context for reviewing scholarly productivity and visibility. These indicators may be considered alongside verified research contributions, publication quality, originality, professional achievements, and documented eligibility criteria. [4]

Conclusion

The supplied profile describes Lang Li as a researcher affiliated with The Ohio State University, with biology identified as the subject area. The reported metrics of 348 documents, 13,802 citations, and an h-index of 61 offer a quantitative snapshot of scholarly activity. Further evaluation should incorporate verified publications, research contributions, and authoritative award documentation to provide a complete and balanced account.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Lang Li, Author ID 35272883700.
    https://www.scopus.com/authid/detail.uri?authorId=35272883700
  2. ORCID. (n.d.). Lang Li: ORCID researcher record. ORCID.
    https://orcid.org/0000-0002-0746-1809
  3. Jin, Y., Desta, Z., Stearns, V., Ward, B., Ho, H., Lee, K.-H., Skaar, T., Storniolo, A. M., Li, L., Araba, A., Blanchard, R., Nguyen, A., Ullmer, L., Hayden, J., Lemler, S., Weinshilboum, R. M., Rae, J. M., Hayes, D. F., & Flockhart, D. A. (2005). CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. Journal of the National Cancer Institute, 97(1), 30–39.
    https://doi.org/10.1093/jnci/dji005
  4. Borges, S., Desta, Z., Li, L., Skaar, T. C., Ward, B. A., Nguyen, A., Jin, Y., Storniolo, A. M., & Nikoloff, D. M. (2006). Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment. Clinical Pharmacology & Therapeutics.
    https://doi.org/10.1016/j.clpt.2006.03.013
  5. International Research Awards. (n.d.). Official awards website.
    https://researchawards.net/

Marianna Olivadese | Agricultural and Biological Sciences | Research Excellence Award

Published on by Research Awards

Research Excellence Award

Marianna Olivadese
Affiliation University of Bologna
Country Italy
Scopus ID 58032601500
Documents 15
Citations 162
h-index 5
Subject Area Agricultural and Biological Sciences
Event International Research Awards
ORCID 0009-0008-6228-8923

Marianna Olivadese
University of Bologna, Italy

The Research Excellence Award recognizes researchers whose scholarly activities demonstrate sustained academic quality, methodological rigor, and meaningful contributions to their respective disciplines. Marianna Olivadese, affiliated with the University of Bologna, has established a research profile within the field of Agricultural and Biological Sciences through peer-reviewed publications, interdisciplinary collaboration, and measurable scholarly impact. Bibliometric indicators, including indexed publications, citations, and h-index values, provide quantitative evidence supporting the visibility and influence of her research within the international scientific community.[1]

Abstract

Marianna Olivadese’s academic profile reflects research activities focused on Agricultural and Biological Sciences, emphasizing scientific investigation, evidence-based methodology, and interdisciplinary collaboration. Her scholarly output, indexed in international bibliographic databases, demonstrates continued engagement with contemporary research questions while contributing to the advancement of knowledge through peer-reviewed publications and collaborative research initiatives.[1][2]

Keywords

Agricultural and Biological Sciences; Sustainable Agriculture; Environmental Research; Scientific Collaboration; Research Evaluation; Scopus; Bibliometrics; Academic Recognition; Research Excellence; University of Bologna.

Introduction

Research excellence is commonly evaluated through a combination of scientific quality, publication performance, citation influence, collaborative engagement, and contribution to disciplinary advancement. International academic recognition programs increasingly consider both qualitative and quantitative indicators when assessing researchers whose work demonstrates sustained scientific relevance. Marianna Olivadese’s publication record contributes to this evaluation framework through measurable academic productivity and scholarly dissemination.[1]

Research Profile

Marianna Olivadese is affiliated with the University of Bologna, Italy, and has established an internationally indexed research profile in Agricultural and Biological Sciences. According to Scopus author metrics, her scholarly record includes 15 indexed documents, 162 citations, and an h-index of 5, reflecting continued academic engagement and citation visibility across the scientific literature.[1]

Research Contributions

The research activities associated with Marianna Olivadese emphasize scientific investigation supporting agricultural and biological systems through evidence-based methodologies. Her publications contribute to ongoing discussions concerning sustainable resource management, biological processes, environmental interactions, and related interdisciplinary themes within agricultural sciences. Collaboration with other researchers further strengthens knowledge dissemination and scientific development.[1][3]

Publications

The publication portfolio includes peer-reviewed journal articles indexed within recognized scientific databases. These publications collectively demonstrate research continuity, scholarly collaboration, and contributions to agricultural and biological science literature. Representative publications are associated with persistent digital identifiers that facilitate long-term accessibility and citation tracking.[2]

Research Impact

Citation metrics indicate that Marianna Olivadese’s research has attracted scholarly attention within the international research community. With 162 citations and an h-index of 5, her work demonstrates measurable academic influence while contributing to scientific dialogue and knowledge exchange within Agricultural and Biological Sciences. Such bibliometric indicators are commonly considered alongside qualitative assessments during research evaluation processes.[1][4]

Award Suitability

Based upon available bibliometric information, institutional affiliation, publication activity, and demonstrated citation performance, Marianna Olivadese presents a research profile consistent with the objectives of the International Research Awards. Her sustained scholarly productivity, international indexing, and contribution to Agricultural and Biological Sciences support consideration for recognition under the Research Excellence Award category while reflecting established standards of academic achievement.[1]

Conclusion

Marianna Olivadese’s scholarly profile demonstrates continued participation in internationally recognized scientific research through peer-reviewed publications, measurable citation performance, and interdisciplinary collaboration. These characteristics collectively illustrate a professional academic record that aligns with accepted indicators of research excellence and supports recognition within international academic award programs.[1]

References

  1. Elsevier. (2026). Scopus Author Details: Marianna Olivadese, Author ID 58032601500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58032601500
  2. Marianna Olivadese (2026). University of Bologna.
    DOI: https://sciprofiles.com/profile/2326886
  3. ORCID. (2026). ORCID Record: Marianna Olivadese.
    https://orcid.org/0009-0008-6228-8923
  4. International Research Awards. (2026). Research Excellence Award Program.
    https://researchawards.net/

Marco Miceli | Biology and Life Sciences | Best Paper Award

Published on by Research Awards

Dr. Marco Miceli | Biology and Life Sciences | Best Paper Award 

CEINGE-Biotecnologie Avanzate Franco Salvatore | Italy

Dr. Marco Miceli is an Italian biomedical researcher with over two decades of continuous experience in molecular biology, epigenetics, genetics, and translational biomedical research, developed within leading academic and research institutions in Italy. Born on 20 February 1973, he is currently engaged at CEINGE–Biotecnologie Avanzate “Franco Salvatore” in Naples, where since October 2022 he has been working under a fixed-term collaboration contract within the national project “TASK FORCE 2022 COVID-19”. In this role, he serves as Head of the Level III Biosafety Laboratory (BSL-3), operating under the scientific supervision of Prof. Massimo Zollo, with responsibilities encompassing high-containment laboratory management, advanced virological research, and biosafety compliance. Between 2020 and 2022, Dr. Miceli worked at the University of Naples Federico II, Department of Neurosciences, Reproductive Sciences and Odontostomatology, contributing to a CDA-funded project focused on the molecular etiology of syndromic and non-syndromic genetic hearing loss, including genotype–phenotype correlations and functional characterization of pathogenic variants. His research career has been strongly rooted at CEINGE and associated institutes, where he has held multiple research appointments since 2019, collaborating on projects spanning molecular diagnostics, functional genomics, and advanced cellular models. Earlier in his career, he served as a fixed-term researcher at the IRCCS SDN Research Institute, working on innovative projects involving amniocyte stem cells, 3D scaffolds for bone tissue engineering, and epigenetic profiling of immune cells in metabolic disorders. From 2005 onward, Dr. Miceli played a sustained role in several nationally and EU-funded research programs, including EPITRON, ATLAS, APO-SYS, and PON-SIRTT-IN, primarily under the scientific guidance of Prof. Lucia Altucci. His work during this period focused on epigenetic regulation of gene expression, chromatin immunoprecipitation (ChIP), real-time PCR, histone deacetylase complexes, apoptosis regulation, and cancer epigenetics. Dr. Miceli’s long-standing expertise spans molecular genetics, chromatin biology, lentiviral systems, stem cell models, and translational biomedical research, making him a highly experienced and reliable contributor to multidisciplinary research initiatives at the interface of basic science, clinical research, and advanced biotechnological applications.

Citation Metrics (Google Scholar)

3000
2000
1000
500
400
300
200
100
50
30
10
0

Citations
2756

Documents
39

h-index
25

Citations

Documents

h-index

View Google Scholar Profile
   View Orcid Profile

Featured Publications

Hou-Qun Ying | Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Research Awards

Prof. Hou-Qun Ying | Toxicology and Pharmaceutical Science | Research Excellence Award 

The Second Affiliated Hospital of Nanchang University | China

Dr. Hou-Qun Ying, PhD, born on July 18, 1985, in Shangrao, Jiangxi Province, China, is an accomplished clinical scientist specializing in cancer biomarkers, inflammation-related indices, molecular epidemiology, and therapeutic response prediction. He currently serves as the Vice Director of the Department of Clinical Laboratory Medicine at The Second Affiliated Hospital of Nanchang University, where he plays a leading role in translational research, diagnostic innovation, and clinical laboratory management. Dr. Ying earned his Ph.D. in Clinical Laboratory Diagnosis from Southeast University (2013–2016), after completing his Master of Medicine in Pathogenic Biology at Dali University and his Bachelor of Medicine in Medical Laboratory Science from Tianjin Medical University. His academic and professional journey reflects strong expertise in cancer diagnostics, genetic polymorphisms, biomarker development, and precision medicine. Dr. Ying has successfully led multiple competitive research grants, including the National Natural Science Foundation of China Youth Fund (2018–2020), exploring Hippo-pathway-related genetic variations and EGFR-TKI resistance in non-small cell lung cancer, and the 2024–2027 Regional Fund focusing on SP1 transcription factor–related genetic variations as biomarkers for bevacizumab resistance in metastatic colorectal cancer. His research contributions span more than 70 peer-reviewed publications, with many as first, co-first, or corresponding author in high-impact journals such as Scientific Reports, Oncotarget, Cancer Medicine, Therapeutic Advances in Medical Oncology, Frontiers in Oncology, Pharmacological Research, Biomarkers, Future Oncology, and J Inflammation Research. His studies have provided pivotal insights into inflammatory markers such as fibrinogen-to-pre-albumin ratio, albumin-to-fibrinogen ratio, dNLR, PLR, and novel composite biomarkers for cancer prognosis, treatment response prediction, early diagnosis, and recurrence risk stratification. He has also made influential contributions to colorectal cancer, gastric cancer, gallbladder carcinoma, hepatocellular carcinoma, and NSCLC through biomarker innovation, clinical prediction models, and meta-analytic evaluations. As a corresponding author, Dr. Ying has developed and validated numerous inflammation-based and genetic biomarker signatures, such as FPR, ADS score, MLPAS, CCMLP, and chronic inflammation indices, improving precision therapeutic decisions for chemotherapy, bevacizumab, 5-FU–based regimens, and TKIs. Additionally, his collaborative work extends to machine learning applications in early gastric cancer prediction, molecular mechanisms underlying cancer progression, and multi-omics approaches. With a distinguished record of scientific leadership, grant success, and impactful publications, Dr. Ying continues to advance clinical oncology diagnostics and personalized treatment strategies through rigorous research, innovation, and interdisciplinary collaboration.

Profiles: Scopus | Orcid

Featured Publications

Peng, Y., Shang, R., Wang, Z.-J., Ye, Q.-Y., Tang, X.-Y., Cheng, X.-X., & Ying, H.-Q. (2025). Chronic inflammatory comprehensive signature predicts oxaliplatin and 5-fluorouracil benefit in early colorectal cancer. Drug Design, Development and Therapy. https://doi.org/10.2147/DDDT.S556619

Lu, Y., Ye, Q.-Y., Mei, O., Li, Y.-N., Peng, Y., Ying, H.-Q., & Cheng, X.-X. (2025). Chronic inflammation index-based tumor subsite classification correlated with chemotherapy benefit and survival outcomes in stage II–III colorectal cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S517378

Ye, Q.-Y., Wang, Y.-Y., Wang, Z.-J., Lu, M., Peng, H.-X., Wang, X., Cheng, X.-X., & Ying, H.-Q. (2025). Robust predictive performance of MLPAS and CCMLP for clinical outcome and risk stratification in patients with colorectal cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S498028

Tian, H., Liu, Z., Zhang, Z., Zhang, L., Zong, Z., Liu, J., Ying, H., & Li, H. (2023). Clinical significance of fibrinogen and platelet to pre-albumin ratio in predicting the prognosis of advanced gastric cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S412033

Ying, H.-Q., Liao, Y.-C., Luo, Y.-R., Xiong, G., Huang, Y., Nie, R.-W., Xiong, C.-F., & Cheng, X.-X. (2021). Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naïve patients with advanced NSCLC. Pharmacological Research, 105734. https://doi.org/10.1016/j.phrs.2021.105734

Ying, H.-Q., You, X.-H., Liao, Y.-C., Sun, F., & Cheng, X.-X. (2021). High-grade inflammation attenuates chemosensitivity and confers poor survival of surgical stage III CRC patients. Frontiers in Oncology, 11, 580455. https://doi.org/10.3389/fonc.2021.580455

Liao, Y.-C., Ying, H.-Q., Huang, Y., Luo, Y.-R., Xiong, C.-F., Nie, R.-W., Li, X.-J., & Cheng, X.-X. (2021). Role of chronic inflammatory ratios in predicting recurrence of resected patients with stage I–III mucinous colorectal adenocarcinoma. Cancer Management and Research, 13, 303758. https://doi.org/10.2147/CMAR.S303758

Pratiksha Kshirsagar | Pre-clinical pharmacology | Best Researcher Award | 13450

Published on by Research Awards

Ms. Pratiksha Kshirsagar | Pre-clinical pharmacology | Best Researcher Award

Ms. Pratiksha Kshirsagar, University of Nebraska Medical Center, United States

Ms. Pratiksha Kshirsagar is a dedicated pharmaceutical scientist currently pursuing her Ph.D. in Pharmaceutical Sciences at the University of Nebraska Medical Center (UNMC), USA. With strong academic credentials and hands-on research experience in both India and the U.S., she specializes in bioanalytical method development, preclinical pharmacokinetics, and drug delivery systems. Her work includes the development and validation of LC-MS/MS methods and conducting in vitro and in vivo DMPK studies for novel therapeutics targeting medulloblastoma. She has co-authored several peer-reviewed publications and presented her findings at national and international conferences. Ms. Kshirsagar is also a recipient of the UNMC Dean of Graduate Studies Conference Attendance Award and remains committed to advancing pharmaceutical research and translational drug development.

Profile

ORCID

🎓 Early Academic Pursuits

Pratiksha Kshirsagar’s academic journey is marked by consistent dedication and a keen interest in pharmaceutical sciences. Her educational foundation was laid at Savitribai Phule Pune University, where she earned both her Bachelor of Pharmacy (2016–2020) with an SGPA of 7.7/10 and a Master of Pharmacy in Pharmaceutics (2020–2022), graduating with distinction (SGPA: 8.96/10). These formative years laid the groundwork for her strong research acumen and laboratory skills. Keen to explore further, she transitioned to the University of Nebraska Medical Center (UNMC), USA, where she pursued a Master of Pharmaceutical Sciences (2022–2024). Her academic growth culminated in her enrollment in the Ph.D. program in Pharmaceutical Sciences (2024–2029). With a GPA of 3.6/4.0, her progress has been both steady and impressive. Simultaneously, she earned a Certificate in Applied Biostatistics with a perfect GPA of 4.0/4.0, showcasing her commitment to interdisciplinary learning and data-driven research.

🧪 Professional Endeavors

Pratiksha’s professional experience is deeply intertwined with her academic path, reflecting a rare blend of scholarly rigor and hands-on application. At UNMC, under the mentorship of Dr. Daryl J. Murry, she has worked extensively as a graduate research assistant and student researcher, contributing to the development and validation of LC-MS/MS bioanalytical methods for novel small molecules and RIPTACs. Her earlier professional journey in India involved impactful research under Dr. Smita S. Pimple, where she explored micro-emulsions using essential oils and carrier oils for skincare applications. This early exposure to formulation science, coupled with analytical chemistry, gave her a solid foundation in pharmaceutics and laboratory research.

🔬 Contributions and Research Focus

Pratiksha’s primary research focus lies in drug metabolism and pharmacokinetics (DMPK), with an emphasis on preclinical evaluation of novel therapeutic agents. Her notable contributions include the in-depth pharmacokinetic analysis of EPZ015666 and JNJ-64619178 for medulloblastoma treatment, reflecting her role in advancing pediatric cancer therapy.

Her technical expertise spans several key areas:

  • LC-MS/MS bioanalytical method development

  • In-vitro studies like metabolic stability, protein binding, and drug transporter assays

  • In-vivo animal studies, including oral/IV dosing and tissue distribution

  • Use of Phoenix WinNonlin, GraphPad Prism, and other analytical tools for pharmacokinetic modeling

Moreover, she contributed to the design, characterization, and stability testing of advanced nano drug delivery systems such as S-SNEDDS (Solid Self-Nanoemulsifying Drug Delivery System), which demonstrates her interdisciplinary knowledge.

🏅 Accolades and Recognition

Pratiksha’s dedication has earned her notable recognition throughout her academic and research journey. She was awarded the UNMC Dean of Graduate Studies Conference Attendance Award in 2023, underscoring her academic excellence and potential for contribution at scientific forums.

She actively participated in esteemed conferences such as:

  • American Association of Pharmaceutical Scientists (AAPS), Oct 2023

  • UNMC College of Pharmacy Research Day, May 2023

  • CHRI Pediatric Research Forum, May 2023

In earlier academic years, she was involved in state and national level conferences and poster competitions, including the Medical Coding & E-Poster Competition (2020) and a State Level Seminar on Natural Products Research (2018).

🌍 Impact and Influence

Pratiksha’s research holds real-world significance. Her work on small molecule therapeutics for medulloblastoma contributes to the body of knowledge addressing rare pediatric brain cancers, potentially guiding future clinical interventions. Her cross-functional approach—merging analytical chemistry, pharmacology, and pharmaceutical formulation—makes her an invaluable contributor to translational medicine. She has also co-authored several scholarly publications and book chapters on nanotechnology, drug delivery, and antiviral drug challenges, reinforcing her growing influence in the academic community. These contributions are cited in peer-reviewed journals and academic textbooks, evidencing her thought leadership.

🔮 Legacy and Future Contributions

As Pratiksha continues her Ph.D. journey, her trajectory suggests a future as a leading scientist in pharmaceutical research and drug development. Her interests align with solving complex challenges in drug delivery, pharmacokinetics, and personalized medicine. Looking ahead, she aims to bridge the gap between bench-side research and bedside applications, translating scientific breakthroughs into therapeutic realities. Whether in academia, industry, or clinical collaborations, her vision is clear: to contribute meaningfully to global health innovation.

📄 Publication Top Notes

Crossing the Blood–Brain Barrier: Innovations in Receptor- and Transporter-Mediated Transcytosis Strategies

Contributors: Ling Ding; Pratiksha Kshirsagar; Prachi Agrawal; Daryl J. Murry

Journal: Pharmaceutics

Year: 2025

Preparation and Characterization of Advanced Nano medicine For Malaria: Box Behnken Design Approach

Contributors: Anuradha G. More; Parag R. Potbhare; Padmaja S. Kore; Praveen D. Chaudhari; Pratiksha U. Kshirsagar; Radhika R. Baheti; Surbhi C. Gupta

Journal: International Journal of Life Science and Pharma Research

Year: 2022